9YF0 Stock Overview
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
I.CERAM SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €9.64 |
52 Week High | €16.90 |
52 Week Low | €9.64 |
Beta | 1.1 |
1 Month Change | 0% |
3 Month Change | -7.31% |
1 Year Change | -3.21% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -61.75% |
Recent News & Updates
Recent updates
Shareholder Returns
9YF0 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0% | 1.6% | 2.5% |
1Y | -3.2% | -4.9% | 5.4% |
Return vs Industry: 9YF0 matched the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: 9YF0 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
9YF0 volatility | |
---|---|
9YF0 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 4.5% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.5% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9YF0 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 9YF0's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 27 | André Kérisit | www.iceram.fr |
I.CERAM SA designs, manufactures, and markets alumina-based ceramic implants in France and internationally. It offers implants for various joints of the human body, including skull, spine, hip, tibia, ankle, foot, and thorax, as well as osteosynthesis products. The company was incorporated in 2005 and is headquartered in Limoges, France.
I.CERAM SA Fundamentals Summary
9YF0 fundamental statistics | |
---|---|
Market cap | €2.83m |
Earnings (TTM) | -€772.25k |
Revenue (TTM) | €1.56m |
1.8x
P/S Ratio-3.7x
P/E RatioIs 9YF0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9YF0 income statement (TTM) | |
---|---|
Revenue | €1.56m |
Cost of Revenue | €364.04k |
Gross Profit | €1.20m |
Other Expenses | €1.97m |
Earnings | -€772.25k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | -2.64 |
Gross Margin | 76.69% |
Net Profit Margin | -49.46% |
Debt/Equity Ratio | 123.5% |
How did 9YF0 perform over the long term?
See historical performance and comparison